• Share
  • Email
  • Print

K&L Gates’ Pharma & Biopharma Litigation group delivers its clients extensive experience, knowledge, and technical acumen to handle patent litigation around the world.

In the United States, Germany, Australia, and various arbitration fora, we counsel clients with a global perspective supported by a deep understanding of the science (organic chemistry, molecular biology, biochemistry, and pharmacology) as well as the venues (U.S. district courts, Patent Trial and Appeal Board, Federal Court of Australia, and the Unified Patent Court).

Our team is singularly focused on pharmaceutical patent work with a successful track record of representing pharmaceutical companies in more than 40 Hatch-Waxman cases over the past decade, numerous inter partes review (IPR) proceedings, hundreds of opinions, and thousands of patent applications.

Underpinning our work is a deep understanding of the pharmaceutical industry and technology from first-hand knowledge and experience:

  • 18 intellectual property lawyers with doctorates
  • 27 lawyers and agents with biotechnology-related degrees
  • 21 lawyers and agents with chemistry/chemical degrees
  • 34 with advanced degrees
  • 10 with in-house pharmaceutical experience

Areas of Practice

NameTitleOfficeContact
Associate
P +1.412.355.6338
Partner
P +1.206.370.8101
Partner
P +1.206.370.7653
Associate
P +1.312.807.4436
Associate
P +1.206.370.8025
Patent Attorney
P +61.2.9513.2497
Partner
P +1.617.261.3178
Senior Associate
P +61.3.9205.2062
Partner
P +1.206.370.7947
Associate
P +1.206.370.8090
Partner
P +1.212.536.3910
Partner
P +1.919.466.1115
Partner
P +1.650.798.6719
Associate
P +1.312.807.4325
Partner
P +1.206.370.7605
Associate
P +1.312.807.4315
Partner
P +1.412.355.6271
Partner
P +61.2.9513.2484
Partner
P +61.2.9513.2428
Associate
P +1.312.807.4280
Associate
P +1.617.261.3229
Associate
P +1.206.370.7674
Partner
P +1.212.536.3930
Associate
P +1.206.370.7637
Special Counsel
P +61.2.9513.2437
Partner
P +1.617.261.3150
Partner
P +49.(0)69.945.196.420
Associate
P +1.206.370.7964
Lawyer
P +61.2.9513.2539
Hospira Inc., et al. v. Sylvia Mathews Burwellet al. (D. Md.).  Lead co, unsel for Par as an intervenor-defendant; reversed recall order of Par’s product and obtained a summary judgment in approval and sale of its generic Precedex product.
In re: Certain Consolidated Zoledronic Acid Cases (D.N.J.). Obtained favorable settlement in this launch-at-risk case involving zoledronic acid.
Fresenius Kabi USA, LLC v. Par Sterile Prods., LLC (D.N.J.).  Obtained favorable settlement in this case involving levothyroxine.
Alza Corp. v. Par Pharm., Inc. (D. Del.).  Obtained favorable settlement in this case involving Concerta.
Hyperion Therap., Inc. v. Par Pharm., Inc. (E.D. Tex.) Case involving Ravicti.
Lyne Labs., Inc. v. Par Pharm., Inc. (D. Mass.).  Obtained favorable settlement in this case involving Phoslyra.
AstraZeneca AB v. Par Pharm., Inc. (D. Del.).  Obtained dismissal in this case involving Onglyza.
Par Sterile Products, LLC v. Fresenius KABI USA LLC (N.D. Ill.).
Merck Sharp & Dohme Corp. v. Par Sterile Prods. LLC et al. (D.N.J.).  Represent Par in this case involving Noxafil.
Forest Laboratories, LLC v. Amneal Pharm. LLC (D.Del.).  Represent Par in this case involving Namzaric.